Imageâguided tumor ablative therapies are mainstay cancer treatment options, but often require intraâprocedural protective tissue displacement to reduce the risk of collateral damage to neighboring organs. Standard of care (SoC) strategies, such as hydrodissection (fluidic injection), are limited by rapid diffusion of fluid and poor retention time, risking injury to adjacent organs, increased cancer recurrence rates from incomplete tumor ablations, and limited patient qualification. Herein, we developed âgelâdissection,â a technique leveraging injectable hydrogels for longerâlasting, shapeable, and transient tissue separation, empowering clinicians with improved ablation operation windows and greater control. A rheological model was designed to understand and tune gelâdissection parameters. In swine models, gelâdissection achieved 24 times longerâlasting tissue separation dynamics compared to saline, with 40% less injected volume. Gelâdissection achieved antiâdependent dissection between freeâfloating organs in the peritoneal cavity and clinically significant thermal protection, with the potential to expand minimally invasive therapeutic techniques, especially across locoregional therapies including radiation, cryoablation, endoscopy, and surgery.This article is protected by copyright. All rights reserved